Xeris Biopharma Holdings, Inc. XERS Other Working Capital
Other Working Capital at other companies
Other financials
Where this comes from
Reported directly by Xeris Biopharma Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherOperatingActivitiesCashFlowStatement.
The official record: Xeris Biopharma Holdings, Inc.’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xeris Biopharma Holdings, Inc.'s other working capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xeris Biopharma Holdings, Inc.'s other working capital?
- Xeris Biopharma Holdings, Inc. (XERS) reported other working capital of $0 in Q4 2025.
- How has Xeris Biopharma Holdings, Inc.'s other working capital changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s other working capital decreased by 100.0% year-over-year, from $20.75K to $0.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s other working capital?
- Over 2 years (2023 to 2025), Xeris Biopharma Holdings, Inc.'s other working capital has grown at a -100.0% compound annual growth rate (CAGR), from $320K to $0.
- What does other working capital mean?
- Net change in working capital items not separately classified — a residual balancing item.